Oxy Biopharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 180.12%
- Profit Growth -4.67%
- Ebitda -5.52%
- Net Worth 29.91%
- Total Assets -67.41%
About Oxy Biopharma
Oxy Biopharma Private Limited (OBPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 May 2011 and has a history of 13 years and nine months. Its registered office is in Delhi, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Lovey Tomer and Mayur Jain serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51909DL2011PTC219277
-
Company No.
219277
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 May 2011
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Oxy Biopharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lovey Tomer
|
Director | 16-May-2011 | Current |
|
Mayur Jain
|
Director | 03-Nov-2014 | Current |
Financial Performance of Oxy Biopharma.
Oxy Biopharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 180.12% increase. The company also saw a slight decrease in profitability, with a 4.67% decrease in profit. The company's net worth Soared by an impressive increase of 29.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oxy Biopharma?
In 2016, Oxy Biopharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Oxy Biopharma?
Unlock and access historical data on people associated with Oxy Biopharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oxy Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oxy Biopharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
